A CLINICOPATHOLOGICAL ANALYTIC STUDY OF OVARIAN TUMOURS OVER A TWO-YEAR PERIOD IN A TEACHING HOSPITAL

Authors

  • KOMAL SAHITHI BARLA Department of Obstetrics and Gynecology, GITAM Institute of Medical Sciences and Research, GITAM Deemed to be University, Rushikonda, Visakhapatnam-530045, Andhra Pradesh, India
  • VIJAYALAKSHMI CHANDRASEKHAR Department of Obstetrics and Gynecology, GITAM Institute of Medical Sciences and Research, GITAM Deemed to be University, Rushikonda, Visakhapatnam-530045, Andhra Pradesh, India
  • VASUNDARA G. Department of Pathology, GITAM Institute of Medical Sciences and Research, GITAM Deemed to be University, Rushikonda, Visakhapatnam-530045, Andhra Pradesh, India
  • B. V. MADHAVI Department of Pathology, GITAM Institute of Medical Sciences and Research, GITAM Deemed to be University, Rushikonda, Visakhapatnam-530045, Andhra Pradesh, India

DOI:

https://doi.org/10.22159/ijcpr.2023v15i6.3081

Keywords:

Ovarian tumours, Clinical presentation, Histopathology

Abstract

Objective: The aim of this retrospective study was to analyze the clinical, demographic and pathological aspects of ovarian tumours diagnosed and operated upon over a two-year period.

Methods: A total of sixty women diagnosed with ovarian tumours who underwent an operative procedure formed our study group. All clinical and demographic data were obtained from medical records and the histopathology reports of the tissues removed at surgery were retrieved from the pathology department records.

Results: 36.7% of the women belonged to the age group of 41-50 y and lower abdominal pain was the commonest symptom in 61.7% of the women. 93.10% of the ovarian tumours were found to be benign, 1.7% to be borderline and 5.17% were malignant. Benign surface epithelial tumours constituted 74.13% of the total and, of these the incidence of serous cystadenoma was 44.8% and mucinous cytadenoma 22.41%. Germ cell tumours constituted 13.8% of all the tumours, with mature cystic teratomas being the most prevalent at 12.06%. Serous cystadenocarcinoma accounted for 5.17% of the tumours and borderline serous tumours accounted for 1.72%.

Conclusion: Women presenting with symptoms of an ovarian tumour should undergo a detailed clinical evaluation, investigations, early interventions and histopathology should be an integral component to improve outcomes.

Downloads

Download data is not yet available.

References

Day NE, Krishnan E. Epidemiology of gynaecological cancers. Gynaecology by Shaw RW. 2nd ed. Edinburgh: Churchill Living Stone; 1997. p. 477-87.

Globocan. Estimated cancer Incidence, Mortality, Prevalence and Disability-adjusted life years (DALYs) Worldwide; 2008. Available from: http://globocan.fr:iarc/. [Last accessed on 28 Oct 2012]

Murthy NS, Shalini S, Suman G, Pruthvish S, Mathew A. Changing trends in incidence of ovarian cancer–the Indian scenario. Asian Pac J Cancer Prev. 2009;10(6):1025-30. PMID 20192577.

Gupta N, Bisht D, Agarwal AK, Sharma VK. Retrospective and prospective study of ovarian tumours and tumor-like lesions. Indian J Pathol Microbiol. 2007;50(3):525-7. PMID 17883123.

Mondal SK, Banyopadhyay R, Nag DR, Roychowdhury S, Mondal PK, Sinha SK. Histologic pattern, bilaterality and clinical evaluation of 957 ovarian neoplasms: a 10 y study in a tertiary hospital of eastern India. J Cancer Res Ther. 2011;7(4):433-7. doi: 10.4103/0973-1482.92011, PMID 22269405.

Swamy GG, Satyanarayana M. Clinicopathological analysis of ovarian tumors-a study on five year’s samples. J Nepal Med Coll. 2010;12(4):221-3.

Sudha V, Harikrishnan V, Sridevi M, Priya P. Clincipathological correlation of ovarian tumors in a tertiary care hospital. Ind J Pathol Oncol. 2018;5(2):332-7.

Jain R, Patel P, Goyal S. Clinicopathological study of ovarian tumors at tertiary care hospital, Udaipur. Int J Reprod Contracept Obstet Gynecol. 2021;10(2):555-8. doi: 10.18203/2320-1770.ijrcog20210301.

Manjusha J, Dweep J, Mrinalini S, Viraj N. Clinicopathological study of ovarian cancer: a multicentered study. J Shaheed Suhrawardy Med Coll. 2013;5:3-6.

Yogambal DM, Arunalatha DP, Chandramouleeswari DK, Palaniappan DV. Ovarian tumours- incidence and distribution in a tertiary referral center in South India. IOSRJDMS. 2014;13(2):74-80. doi: 10.9790/0853-13237480.

Prakash A, Chinthakindi S. Histopathological study of ovarian lesions in a tertiary care centre in Hyderabad, India; A retrospective 5 y study. Ind J Clin Diagn Res. 2017;4(3):745-9.

Couto F, Naolkami NS, Jose M. Ovarian tumours in Goa-a clinicopathologicval study. J Obstet Gynecol India. 1993;43:403-12.

Kiranmayi BVVD, Kumar K, Bhaskar RV. Histopathological profile of ovarian tumours-a two-year retrospective study. Indian J Sci Res. 2017;6(12):208-10.

Ramachandran G, Hailal KR, Chinamma KK, Thangavelu H. Ovarian neoplasms-a study of 903 cases. J Obstet Gynecol India. 1972;22:309-15.

Gupta SC, Singh PA, Mehrotra TN, Agarwal R. A clinicopathological study of ovarian tumours. Indian J Pathol Microbiol. 1986;29(4):354-62. PMID 3817965.

Kapas MM, Ral MC. Varieties of ovarian neoplasms. J Obstet Gynecol India. 1987;32:810-5.

Published

15-11-2023

How to Cite

BARLA, K. S., V. CHANDRASEKHAR, V. G., and B. V. MADHAVI. “A CLINICOPATHOLOGICAL ANALYTIC STUDY OF OVARIAN TUMOURS OVER A TWO-YEAR PERIOD IN A TEACHING HOSPITAL”. International Journal of Current Pharmaceutical Research, vol. 15, no. 6, Nov. 2023, pp. 77-80, doi:10.22159/ijcpr.2023v15i6.3081.

Issue

Section

Original Article(s)